A Study to Evaluate The Pharmacokinetics Of Crizotinib (PF-02341066) In Subjects With Impaired Renal Function

Status:
Completed

Trial end date:
2012-08-01

Target enrollment:

Participant gender:

The present study is being conducted to evaluate whether or not severe renal impairment has an effect on crizotinib Pharmacokinetics.

Phase 1

Pfizer

Crizotinib